Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...
4d
Barchart on MSNWedbush Says to Ignore the DOGE Noise and Go ‘All In’ on Tesla StockTesla’s (TSLA) stock is in the midst of its longest losing streak since going public 15 years ago, with shares falling for ...
Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on ...
Wedbush Securities is making a big statement on Tesla (NASDAQ:TSLA), naming it to its Best Ideas List even though the stock has had a rough start to the year. According to analyst Dan Ives ...
Nvidia ( NASDAQ: NVDA) is set to host its annual GTC conference next week and with tech stocks under pressure from tariffs, concerns of a recession and negative sentiment, Wedbush Securities believes ...
Analysts at Wedbush believe Palantir could secure additional government contracts following channel checks in Washington, D.C ...
Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...
Wedbush analysts called Palantir one of their "top names" to own in 2025, expecting the stock to benefit from a "tidal wave of spending on AI." ...
7don MSN
At a time when sentiment in the stock is at its most vulnerable in months, Taneja deliberately chose to cash in more of his ...
Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research ...
Analysts at Wedbush issued their FY2029 earnings per share estimates for Elevation Oncology in a research report issued to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results